Pfizer is considering selling its consumer ... It markets two of the ten top-selling consumer healthcare brands – multivitamin tablets Centrum and headache pill Advil. Germany’s Merck KGaA ...

Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million ...

Together with the Consumer Health business this will ... Established Medicines will include Pfizer’s off-patent brands, such as its erectile dysfunction drug Viagra. It will also include Pfizer ...

Pharmaceutical giant Pfizer is mulling the sale or spin-off of its consumer health business, a division that includes brands such as Advil, Robitussin and ChapStick. The company is looking to ...

Pfizer PFE-2.36%decrease; red down pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN 1.12%increase; green up pointing triangle for 2.50 billion ...

To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...

The study provides a comparison of biopharma brands to a sample of consumer brands outside of the pharmaceutical industry. This cross-industry perspective enables biopharma brands to identify ...

(Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner ...